Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Digoxin × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4 Breast 3 Head & Neck 2 Dermatologic 2 Thoracic 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Myeloid 1 Genitourinary 1 Endocrine 1 CNS 1

Conditions

Medulloblastoma 1

Interventions

Temozolomide 398 Radiotherapy 237 Bevacizumab 182 Magnetic Resonance Spectroscopy 164 Radiosurgery 141 Cyclophosphamide 95 Irinotecan 79 Carboplatin 79 Etoposide 78 Radiation 75 pembrolizumab 69 Nivolumab 59 Surgical Procedures, Operative 57 Filgrastim 56 Specimen Handling 52 Cisplatin 50 Topotecan 45 Blood Specimen Collection 44 Vincristine 43 Melphalan 38 Pemetrexed 36 Ipilimumab 36 Radiotherapy, Intensity-Modulated 35 Lomustine 35 Everolimus 35 Magnetic Resonance Imaging 34 Erlotinib Hydrochloride 34 Surveys and Questionnaires 33 Drug Therapy 33 sargramostim 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06701812 2026-02-27

Digoxin Medulloblastoma Study

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡